Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ARH-049020
Cat. No.:
0225LY-0848
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
ARH-049020 functions as a PPAR agonist specifically developed for the investigation and treatment of type 2 diabetes.
Synonym:
ARH049020; X-334; X334; X 334; ARH 049020; 251454-45-2; ARH-049020; (S)-3-(4-(4-((tert-butoxycarbonyl)amino)phenethoxy)phenyl)-2-ethoxypropanoic acid; AR-H 049020XX; (2S)-3-(4-(2-(4-(tert-Butoxycarbonylamino)phenyl)ethoxy)phenyl)-2-ethoxy-propanoic acid; (2S)-2-ethoxy-3-[4-[2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]ethoxy]phenyl]propanoic acid; Benzenepropanoic acid, 4-(2-(4-(((1,1-dimethylethoxy)carbonyl)amino)phenyl)ethoxy)-alpha-ethoxy-, (alphaS)-
CAS No.:
251454-45-2
Compound CID:
9910505
Formula:
C24H31NO6
Formula Weight:
429.51
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ARH-049020 can be used in drug discovery to investigate the modulation of metabolic nuclear receptors.
Library Information
Target:
PPAR
Receptor:
PPAR
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-11
Plate Location:
h7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
